Antiplatelet Therapy in Neuroendovascular Therapeutics
- 28 June 2005
- journal article
- case report
- Published by Elsevier BV in Neurosurgery Clinics of North America
- Vol. 16 (3), 517-540
- https://doi.org/10.1016/j.nec.2005.03.003
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Dipyridamole for Preventing Recurrent Ischemic Stroke and Other Vascular EventsStroke, 2005
- Thrombolysis With Recombinant Tissue Plasminogen Activator and Tirofiban in StrokeStroke, 2003
- Effectiveness of tirofiban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study)The American Journal of Cardiology, 2002
- Acute Basilar Artery Occlusion Treated With Combined Intravenous Abciximab and Intra-arterial Tissue Plasminogen ActivatorStroke, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Abciximab in Acute Ischemic StrokeStroke, 2000
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- Determinants of early recurrence of cerebral infarction. The Stroke Data Bank.Stroke, 1989
- Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplastyAmerican Heart Journal, 1989
- DipyridamoleNew England Journal of Medicine, 1987